A 12-d-old neonate suffering from group B streptococcal septic shock was treated with 24 microg/kg/h recombinant human activated protein C [rhAPC, drotrecogin alpha (activated)] for 96 h. The protein C activity increased from 5% to 53% after rhAPC infusion. The patient recovered within 14 d without any adverse effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/00365540510031412 | DOI Listing |
Publication Analysis
Top Keywords
drotrecogin alpha
8
septic shock
8
alpha activated
4
activated neonatal
4
neonatal septic
4
shock 12-d-old
4
12-d-old neonate
4
neonate suffering
4
suffering group
4
group streptococcal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!